The recommended CO2 laser protocol is staged ablation followed by contour refinement: begin with continuous-wave (CW) CO2 mode to debulk the thick, hypertrophic sebaceous tissue, then switch to short-pulsed or pulsed mode to refine the margins and nasal contour. Local anesthesia, careful depth control, hemostasis, and special attention to the nasal ala and dorsum are essential. Erbium:YAG is less effective for substantial rhinophyma because its minimal thermal coagulation produces rapid bleeding that obscures the field and may force the practitioner to stop before adequate debulking is complete.
CO2 is favored for significant rhinophyma because it combines tissue vaporization with hemostasis. Its safest use depends on removing excess tissue in a controlled plane, preserving viable sebaceous structures for re-epithelialization, and using pulsed energy for precise finishing.
Why the Protocol Must Be Staged
Start With Controlled Gross Debulking
After appropriate local anesthetic nerve blocks, the practitioner begins by reducing the bulk of the phymatous tissue with CO2 laser energy. CW mode is useful for this initial phase because it removes thick tissue efficiently while thermally coagulating small blood vessels.
The handpiece should be moved deliberately in a controlled, overlapping or “airbrush” motion. Depending on the device, tissue thickness, and spot configuration, published techniques describe settings in the approximate 15–30 W range, but these values are device- and patient-dependent rather than universal prescriptions.
Switch to Pulsed Mode for Refinement
Once the major excess has been removed, the practitioner should transition to pulsed or short-pulsed CO2 mode. This allows marginal areas, irregularities, and contour transitions to be adjusted with less cumulative thermal damage and less surface charring.
The final contour should be blended into the surrounding nasal skin rather than ending at a sharply defined treatment boundary. This is particularly important around the alar groove, where excessive removal can cause distortion.
How to Control Treatment Depth
Preserve the Sebaceous Tissue Plane
A key safety endpoint is the continued ability to express sebum from the underlying sebaceous glands with gentle pressure. This suggests that viable glandular structures remain and that ablation has not extended unnecessarily deep.
The goal is to remove hypertrophic tissue while preserving the tissue needed for re-epithelialization. Loss of sebaceous structures or exposure of larger vessels indicates that the practitioner may be approaching an unnecessarily deep plane.
Avoid Focused “Cutting” of Nodules
Practitioners should avoid treating large phymatous nodules as though they were being surgically sliced off with a focused beam. Excessively deep or concentrated ablation increases the risk of scarring and contour defects.
For broad reshaping, defocused energy is commonly used, while focused energy may be reserved for selected bulky areas according to the system’s design and the operator’s training. The beam should remain parallel to the skin when reducing prominent exophytic areas.
Clear the Field Between Passes
Coagulated tissue should be removed between passes with a moist compress or another appropriate method. This exposes the actual treatment surface and helps the operator judge contour, tissue depth, and bleeding more accurately.
Small capillary bleeding may be reduced by defocusing the beam. Larger or persistent vessels may require separate electrocautery or another hemostatic method.
Why CO2 Provides a Practical Advantage
Water Absorption Enables Efficient Ablation
CO2 lasers emit infrared energy at approximately 10,600 nm, a wavelength strongly absorbed by water in tissue. This causes rapid vaporization of water-rich tissue, allowing the practitioner to remove hypertrophic sebaceous tissue and reshape the nose.
Thermal Coagulation Maintains Visibility
The same thermal effect that creates a zone of denatured tissue also coagulates small vessels. This provides substantially better intraoperative hemostasis than techniques with little or no thermal effect.
A relatively clear operative field is important in rhinophyma because contouring requires repeated visual assessment. Bleeding that obscures the surface makes both tissue removal and cosmetic refinement less predictable.
Why Erbium:YAG Is Less Effective for Significant Rhinophyma
Minimal Thermal Damage Means Less Coagulation
Erbium:YAG energy is highly precise and produces minimal peripheral thermal damage. That characteristic supports faster healing and can reduce the risk of scarring or post-inflammatory hyperpigmentation, especially in patients with darker skin phototypes.
However, minimal thermal damage also means less coagulation of small blood vessels. During substantial tissue debulking, bleeding can begin quickly and cover the treatment field.
Bleeding Interrupts Primary Debulking
When the field becomes obscured, the practitioner may be unable to judge tissue depth or contour safely. The procedure may therefore need to be paused or terminated before enough hypertrophic tissue has been removed.
This is why Erbium:YAG is generally less suitable as the primary instrument for moderate to severe rhinophyma, despite its precision. Its limitation is primarily operative visibility and hemostasis, not an inability to ablate tissue at all.
It May Still Have a Role in Selected Cases
Erbium:YAG can be useful when minimal thermal injury and rapid healing are the dominant priorities, particularly for superficial treatment or selected patients. Its suitability depends on disease severity, vascularity, skin type, the device’s pulse characteristics, and the practitioner’s ability to control bleeding.
The clinical choice is therefore a balance between CO2’s stronger hemostasis and Erbium:YAG’s lower thermal injury.
Understanding the Trade-offs
CO2: Better Hemostasis, Greater Thermal Risk
CW CO2 treatment can leave an approximately 1–2 mm zone of thermally denatured tissue, increasing the risk of scarring if energy is excessive or ablation is too deep. Re-epithelialization may take roughly three to four weeks, depending on treatment extent and patient factors.
The procedure also requires patience. Rapid tissue removal without repeated depth and contour checks increases the risk of over-ablation, alar distortion, and poor cosmetic blending.
Erbium:YAG: Faster Healing, More Intraoperative Bleeding
Erbium:YAG generally causes less collateral thermal injury and may support re-epithelialization in approximately two to three weeks. It may also carry a lower risk of post-inflammatory hyperpigmentation and scarring in appropriate patients.
Its disadvantage is that limited coagulation can produce persistent bleeding, while limited ablation depth per pulse may make substantial rhinophyma removal slower and more difficult to control.
Device Settings Cannot Be Applied Rigidly
Power, spot size, pulse duration, scanner behavior, and tissue response vary considerably between laser systems. Reported values such as 15–25 W for broad CW ablation or smaller spots for focal reduction should be treated as examples from clinical techniques, not as a substitute for device-specific training and titration.
The operator should follow the laser manufacturer’s instructions, institutional protocols, and applicable clinical standards.
How to Apply This to Clinical Practice
The following principles should guide treatment planning and execution:
- If your primary focus is efficient removal of moderate to severe rhinophyma: Use staged CO2 treatment, beginning with controlled CW debulking and finishing with pulsed contour refinement to preserve visibility and improve shaping.
- If your primary focus is minimizing thermal injury or treating a patient at higher risk of pigmentary change: Consider whether Erbium:YAG is appropriate for the treatment extent, while planning explicitly for greater bleeding and potentially slower debulking.
- If your primary focus is preventing scarring: Stop within the sebaceous tissue plane, confirm continued sebaceous expression, and avoid deep focused cutting or aggressive treatment near the nasal ala.
- If your primary focus is maintaining a usable operative field: Use CO2’s coagulative advantage, clear coagulated tissue between passes, and control larger vessels with appropriate adjunctive hemostasis.
A well-executed rhinophyma procedure matches the laser’s hemostatic and ablative characteristics to disease severity while preserving tissue depth, nasal architecture, and the patient’s healing potential.
Summary Table:
| Aspect | CO2 Laser | Erbium:YAG |
|---|---|---|
| Hemostasis | Good (coagulates vessels) | Poor (minimal coagulation) |
| Ablation efficiency | High | Moderate |
| Thermal damage | Higher (1-2 mm) | Lower |
| Healing time | 3-4 weeks | 2-3 weeks |
| Suitable for severe rhinophyma | Yes | Less suitable |
Elevate your practice with BELIS's advanced laser systems, including CO2 and Erbium:YAG devices, designed for clinics and premium salons. Our professional-grade technology ensures precise, safe, and effective treatments. Contact us today to learn how our solutions can enhance patient outcomes and grow your business. Get in touch now to explore our full range of aesthetic equipment.
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Cryolipolysis Fat Freezing Machine Cavitation Lipo Laser Machine
- Multifunctional Laser Hair Growth Machine Device for Hair Growth
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- How do energy-based modalities complement injectable neurotoxins in décolleté rejuvenation? Explore synergistic benefits.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
